
Kevin E. Weddington
Examiner (ID: 6966)
| Most Active Art Unit | 1614 |
| Art Unit(s) | 1614, 1205, 1629, 2899 |
| Total Applications | 3386 |
| Issued Applications | 2180 |
| Pending Applications | 434 |
| Abandoned Applications | 815 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5771650
[patent_doc_number] => 20050267101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-01
[patent_title] => 'Treatment of diseases using ICE inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/140649
[patent_app_country] => US
[patent_app_date] => 2005-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15678
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20050267101.pdf
[firstpage_image] =>[orig_patent_app_number] => 11140649
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/140649 | Treatment of diseases using ICE inhibitors | May 26, 2005 | Issued |
Array
(
[id] => 4670507
[patent_doc_number] => 20080045567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-21
[patent_title] => 'Therapeutic Agent for Hyperlipemia and Therapeutic Agent for Diabetes'
[patent_app_type] => utility
[patent_app_number] => 11/628225
[patent_app_country] => US
[patent_app_date] => 2005-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2668
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20080045567.pdf
[firstpage_image] =>[orig_patent_app_number] => 11628225
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/628225 | Therapeutic Agent for Hyperlipemia and Therapeutic Agent for Diabetes | May 26, 2005 | Abandoned |
Array
(
[id] => 7225437
[patent_doc_number] => 20050261349
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-24
[patent_title] => 'Medicine for prevention or treatment of diabetes'
[patent_app_type] => utility
[patent_app_number] => 11/132513
[patent_app_country] => US
[patent_app_date] => 2005-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2304
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0261/20050261349.pdf
[firstpage_image] =>[orig_patent_app_number] => 11132513
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/132513 | Medicine for prevention or treatment of diabetes | May 18, 2005 | Abandoned |
Array
(
[id] => 5771949
[patent_doc_number] => 20050267221
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-01
[patent_title] => 'Use of curcumin and analogues thereof as inhibitors of ACC2'
[patent_app_type] => utility
[patent_app_number] => 11/128888
[patent_app_country] => US
[patent_app_date] => 2005-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11040
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20050267221.pdf
[firstpage_image] =>[orig_patent_app_number] => 11128888
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/128888 | Use of curcumin and analogues thereof as inhibitors of ACC2 | May 12, 2005 | Abandoned |
Array
(
[id] => 260056
[patent_doc_number] => 07572782
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-08-11
[patent_title] => 'Use of targeted oxidative therapeutic formulation in bone regeneration'
[patent_app_type] => utility
[patent_app_number] => 11/125773
[patent_app_country] => US
[patent_app_date] => 2005-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7019
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/572/07572782.pdf
[firstpage_image] =>[orig_patent_app_number] => 11125773
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/125773 | Use of targeted oxidative therapeutic formulation in bone regeneration | May 9, 2005 | Issued |
Array
(
[id] => 7250470
[patent_doc_number] => 20050272714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-08
[patent_title] => 'Use of targeted oxidative therapeutic formulation in treatment of diabetes and obesity'
[patent_app_type] => utility
[patent_app_number] => 11/122907
[patent_app_country] => US
[patent_app_date] => 2005-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6782
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0272/20050272714.pdf
[firstpage_image] =>[orig_patent_app_number] => 11122907
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/122907 | Use of targeted oxidative therapeutic formulation in treatment of type 2 diabetes | May 4, 2005 | Issued |
Array
(
[id] => 4910282
[patent_doc_number] => 20080021049
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-24
[patent_title] => 'Treatment Of Diet-Related Conditions Using Phospholipase-A2 Inhibitors Comprising Indoles And Related Compounds'
[patent_app_type] => utility
[patent_app_number] => 11/579253
[patent_app_country] => US
[patent_app_date] => 2005-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 26488
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20080021049.pdf
[firstpage_image] =>[orig_patent_app_number] => 11579253
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/579253 | Treatment Of Diet-Related Conditions Using Phospholipase-A2 Inhibitors Comprising Indoles And Related Compounds | May 2, 2005 | Abandoned |
Array
(
[id] => 5230278
[patent_doc_number] => 20070292385
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-20
[patent_title] => 'Phospholipase Inhibitors Localized in the Gastrointestinal Lumen'
[patent_app_type] => utility
[patent_app_number] => 11/579251
[patent_app_country] => US
[patent_app_date] => 2005-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 39920
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 27
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20070292385.pdf
[firstpage_image] =>[orig_patent_app_number] => 11579251
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/579251 | Phospholipase Inhibitors Localized in the Gastrointestinal Lumen | May 2, 2005 | Abandoned |
Array
(
[id] => 5040282
[patent_doc_number] => 20070092564
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-26
[patent_title] => 'Orally distintegrating formulation and process for preparing the same'
[patent_app_type] => utility
[patent_app_number] => 11/568474
[patent_app_country] => US
[patent_app_date] => 2005-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6188
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20070092564.pdf
[firstpage_image] =>[orig_patent_app_number] => 11568474
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/568474 | Orally distintegrating formulation and process for preparing the same | Apr 29, 2005 | Issued |
Array
(
[id] => 7251047
[patent_doc_number] => 20050272790
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-08
[patent_title] => 'Galenic formulations of organic compounds'
[patent_app_type] => utility
[patent_app_number] => 11/119273
[patent_app_country] => US
[patent_app_date] => 2005-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9442
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0272/20050272790.pdf
[firstpage_image] =>[orig_patent_app_number] => 11119273
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/119273 | Galenic formulations of organic compounds | Apr 28, 2005 | Issued |
Array
(
[id] => 7070048
[patent_doc_number] => 20050245433
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-03
[patent_title] => 'Materials and methods for modulating metabolism'
[patent_app_type] => utility
[patent_app_number] => 11/118737
[patent_app_country] => US
[patent_app_date] => 2005-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 14572
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0245/20050245433.pdf
[firstpage_image] =>[orig_patent_app_number] => 11118737
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/118737 | Methods for modulating metabolism | Apr 28, 2005 | Issued |
Array
(
[id] => 7056404
[patent_doc_number] => 20050277579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-15
[patent_title] => 'Compositions for affecting weight loss'
[patent_app_type] => utility
[patent_app_number] => 11/117139
[patent_app_country] => US
[patent_app_date] => 2005-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6534
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0277/20050277579.pdf
[firstpage_image] =>[orig_patent_app_number] => 11117139
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/117139 | Compositions for affecting weight loss | Apr 26, 2005 | Abandoned |
Array
(
[id] => 4432356
[patent_doc_number] => 07968594
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-06-28
[patent_title] => 'Pharmaceutical compositions for the treatment of pain'
[patent_app_type] => utility
[patent_app_number] => 11/115983
[patent_app_country] => US
[patent_app_date] => 2005-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7973
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/968/07968594.pdf
[firstpage_image] =>[orig_patent_app_number] => 11115983
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/115983 | Pharmaceutical compositions for the treatment of pain | Apr 26, 2005 | Issued |
Array
(
[id] => 4910319
[patent_doc_number] => 20080021086
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-24
[patent_title] => 'Pharmaceutical Composition for Prevention or Treatment of Lipid Metabolism Disorder'
[patent_app_type] => utility
[patent_app_number] => 11/596109
[patent_app_country] => US
[patent_app_date] => 2005-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3406
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20080021086.pdf
[firstpage_image] =>[orig_patent_app_number] => 11596109
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/596109 | Pharmaceutical composition for treatment of lipid metabolism disorder | Apr 26, 2005 | Issued |
Array
(
[id] => 7051366
[patent_doc_number] => 20050187253
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-25
[patent_title] => 'Medicinal kit to quit tobacco consumption comprising central cannabinoid receptor antagonist'
[patent_app_type] => utility
[patent_app_number] => 11/113864
[patent_app_country] => US
[patent_app_date] => 2005-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2363
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20050187253.pdf
[firstpage_image] =>[orig_patent_app_number] => 11113864
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/113864 | Medicinal kit to quit tobacco consumption comprising central cannabinoid receptor antagonist | Apr 24, 2005 | Abandoned |
Array
(
[id] => 5813227
[patent_doc_number] => 20060083783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-20
[patent_title] => 'Treating metabolic syndrome with fenofibrate'
[patent_app_type] => utility
[patent_app_number] => 11/111971
[patent_app_country] => US
[patent_app_date] => 2005-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3784
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0083/20060083783.pdf
[firstpage_image] =>[orig_patent_app_number] => 11111971
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/111971 | Treating metabolic syndrome with fenofibrate | Apr 21, 2005 | Issued |
Array
(
[id] => 6966014
[patent_doc_number] => 20050232911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-20
[patent_title] => 'Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid'
[patent_app_type] => utility
[patent_app_number] => 11/109148
[patent_app_country] => US
[patent_app_date] => 2005-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11938
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20050232911.pdf
[firstpage_image] =>[orig_patent_app_number] => 11109148
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/109148 | Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid | Apr 18, 2005 | Abandoned |
Array
(
[id] => 6925420
[patent_doc_number] => 20050238675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-27
[patent_title] => 'Water-soluble formulations of fat soluble vitamins and pharmaceutical agents and their applications'
[patent_app_type] => utility
[patent_app_number] => 11/109548
[patent_app_country] => US
[patent_app_date] => 2005-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4082
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0238/20050238675.pdf
[firstpage_image] =>[orig_patent_app_number] => 11109548
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/109548 | Water-soluble formulations of fat soluble vitamins and pharmaceutical agents and their applications | Apr 18, 2005 | Abandoned |
Array
(
[id] => 7138344
[patent_doc_number] => 20050182064
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-18
[patent_title] => 'Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy'
[patent_app_type] => utility
[patent_app_number] => 11/108277
[patent_app_country] => US
[patent_app_date] => 2005-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7952
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20050182064.pdf
[firstpage_image] =>[orig_patent_app_number] => 11108277
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/108277 | Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy | Apr 17, 2005 | Issued |
Array
(
[id] => 6959766
[patent_doc_number] => 20050215632
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-29
[patent_title] => 'Preventive or remedy for hypertension'
[patent_app_type] => utility
[patent_app_number] => 11/106428
[patent_app_country] => US
[patent_app_date] => 2005-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4597
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20050215632.pdf
[firstpage_image] =>[orig_patent_app_number] => 11106428
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/106428 | Remedy for hypertension | Apr 14, 2005 | Issued |